School of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK.
Bristol Myers Squibb, Reeds Lane, Moreton, Wirral, CH46 1QW, UK.
AAPS PharmSciTech. 2020 Aug 2;21(6):218. doi: 10.1208/s12249-020-01773-2.
The attrition of drug particles during the process of dry granulation, which may (or may not) be incorporated into granules, could be an important factor in determining the subsequent performance of that granulation, including key factors such as sticking to punches and bio-performance of the dosage form. It has previously been demonstrated that such attrition occurs in one common dry granulation process train; however, the fate of these comminuted particles in granules was not determined. An understanding of the phenomena of attrition and incorporation into granule will improve our ability to understand the performance of granulated systems, ultimately leading to an improvement in our ability to optimize and model the process. Unique feeding mechanisms, geometry, and milling systems of roller compaction equipment mean that attrition could be more or less substantial for any given equipment train. In this work, we examined attrition of API particles and their incorporation into granule in an equipment train from Gerteis, a commonly used equipment train for dry granulation. The results demonstrate that comminuted drug particles can exist free in post-milling blends of roller compaction equipment trains. This information can help better understand the performance of the granulations, and be incorporated into mechanistic models to optimize such processes.
在干法制粒过程中,药物颗粒的磨损(可能会也可能不会)被纳入颗粒中,这可能是决定该制粒后续性能的一个重要因素,包括关键因素如冲头粘附和剂型的生物性能。此前已经证明,这种磨损会在一个常见的干法制粒工艺中发生;然而,这些被粉碎的颗粒在颗粒中的命运尚未确定。对磨损和纳入颗粒现象的理解将提高我们理解颗粒系统性能的能力,最终提高我们优化和模拟工艺的能力。辊压设备独特的给料机制、几何形状和粉碎系统意味着,对于任何给定的设备系列,磨损都可能或多或少地严重。在这项工作中,我们研究了 API 颗粒在 Gerteis 设备系列中的磨损及其在颗粒中的纳入情况,这是一种常用于干法制粒的设备系列。结果表明,粉碎后的药物颗粒可以在辊压设备系列的后粉碎混合物中自由存在。这些信息可以帮助更好地理解制粒的性能,并将其纳入机械模型中以优化这些工艺。